Objective
To compare medicine prices of New Zealand and 16 European countries.
Methods

Results
Medicine prices ranked per quartile. Frequency of country-specific medicine price data ranking in quartiles, including its rank as lowest (min.) or highest (max.). Data in brackets refer to on-patent medicines only.  EL and PT, and, to a lesser extent, ES, UK and NL frequently ranked at the lower end  CH and DE, but also DK and SE ranked at the higher end  NZ results showed high variability Price differences between highest and lowest priced medicine, in per cent based on the lowest priced medicine  For most selected medicines, the price of the product in the highest-priced country was at least twice the price in the lowest-priced country  For few medicines cross-country price differences varied up to 1000% European versus New Zealand prices. NZ prices compared to the price range (min. & max. value), median + average value of the European prices European versus New Zealand prices. NZ prices (in blue, right to the bar) compared to the price range (min. and max. value) and median value of the European prices (European median left to the bar). Ex-factory unit prices in Euro for 16 presentations (11 on-patent medicines plus comparable generic version to 5 on-patent medicines).
Conclusion
Medicine prices varied considerably between European countries and New Zealand as well as among the European countries.
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